Bone marrow aplasia following dipyrone treatment in a patient with Crohn's disease receiving long-term methotrexate;Aplasie médultaire après prise de noramidopyrine chez une malade traitée au long cours par méthotrexate pour maladie de Crohn

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 5, 2004, Pages 502-503

  Blanchet, Eloi ^a   Beau, Philippe ^a   Frat, Jean Pierre ^a  

^a University of Poitiers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRONE; FOLIC ACID; GRANOCYTE 13 34; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; NORAMIDOPYRINE; OMEPRAZOLE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TIEMONIUM IODIDE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALOPECIA; ARTICLE; BONE MARROW APLASIA; CASE REPORT; CORTICOSTEROID THERAPY; CROHN DISEASE; FEMALE; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; PANCYTOPENIA; PARENTERAL NUTRITION; RESUSCITATION; VITAMIN SUPPLEMENTATION; APLASTIC ANEMIA; CHEMICALLY INDUCED DISORDER; NOTE; TIME;

ADULT; ANEMIA, APLASTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; DIPYRONE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; TIME FACTORS;

EID: 3042633336     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)94973-1     Document Type: Article

References (6)

1. Bellaiche G, Maisonneuve L, Nouts A, Ley G, Slama JL. Aplasie médullaire mortelle après la première injection de méthotrexate chez une femme ayant une maladie de Crohn. Gastroenterol Clin Biol 1999;23:1102-3.
2. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1998;51:1357-65.
3. Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 1996;39:272-6.
4. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995;332: 292-7.
5. Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000;342:1627-32.
6. Uwai Y, Saito H, Inui K. Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter. Eur J Pharmacol 2000;409:31-6.